QIA spearheaded the fundraising, and several of BETA's most significant investors, including Fidelity Management & Research Company and TPG Rise Climate, increased their stake in BETA. United Therapeutics, a long-standing customer, also joined this round as an investor. The financing round was priced at a higher valuation compared to previous equity capital raises and was significantly oversub